These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8030399)

  • 21. Timing of birth and disease progression in multiple sclerosis.
    Koch M; De Keyser J; Tremlett H
    Mult Scler; 2008 Jul; 14(6):793-8. PubMed ID: 18573829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Seasonal variation in disseminated sclerosis].
    Bisgård C
    Ugeskr Laeger; 1990 Apr; 152(16):1160-1. PubMed ID: 2330640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry.
    Koch-Henriksen N; Hyllested K
    Acta Neurol Scand; 1988 Nov; 78(5):369-80. PubMed ID: 3218443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sibship characteristics and risk of multiple sclerosis: a nationwide cohort study in Denmark.
    Bager P; Nielsen NM; Bihrmann K; Frisch M; Wohlfart J; Koch-Henriksen N; Melbye M; Westergaard T
    Am J Epidemiol; 2006 Jun; 163(12):1112-7. PubMed ID: 16675539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of multiple sclerosis in British Columbia.
    Sweeney VP; Sadovnick AD; Brandejs V
    Can J Neurol Sci; 1986 Feb; 13(1):47-51. PubMed ID: 3955451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short and long term variation in ultraviolet radiation and multiple sclerosis.
    Menni C; Lowell WE; Bentzen J; Bergamaschi R; Martinelli Boneschi F; Martinelli V; Bernardinelli L; Stenager E; Davis GE; Foco L
    Int J Environ Res Public Health; 2012 Mar; 9(3):685-97. PubMed ID: 22690156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of birth and risk of multiple sclerosis in the Scottish population.
    Bayes HK; Weir CJ; O'Leary C
    Eur Neurol; 2010; 63(1):36-40. PubMed ID: 20029213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age at Menarche and Risk of Multiple Sclerosis: A Prospective Cohort Study Based on the Danish National Birth Cohort.
    Nielsen NM; Harpsøe M; Simonsen J; Stenager E; Magyari M; Koch-Henriksen N; Baker JL; Hjalgrim H; Frisch M; Bager P
    Am J Epidemiol; 2017 Apr; 185(8):712-719. PubMed ID: 28369233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection-related health care utilization among people with and without multiple sclerosis.
    Wijnands JM; Kingwell E; Zhu F; Zhao Y; Fisk JD; Evans C; Marrie RA; Tremlett H
    Mult Scler; 2017 Oct; 23(11):1506-1516. PubMed ID: 28273769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
    Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
    J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis progression is not associated with birth timing in Italy.
    Lucenti A; Galimberti S; Barizzone N; Naldi P; ; ; Comi G; Martinelli Boneschi F; D'Alfonso S; Leone MA
    J Neurol Sci; 2014 Nov; 346(1-2):194-6. PubMed ID: 25194635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
    Shirani A; Zhao Y; Kingwell E; Rieckmann P; Tremlett H
    Mult Scler; 2012 Apr; 18(4):442-50. PubMed ID: 21952097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. School-based hepatitis B vaccination programme and adolescent multiple sclerosis.
    Sadovnick AD; Scheifele DW
    Lancet; 2000 Feb; 355(9203):549-50. PubMed ID: 10683009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study.
    Koch-Henriksen N; Brønnum-Hansen H; Hyllested K
    Neuroepidemiology; 1992; 11(1):1-10. PubMed ID: 1608488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive history and risk of multiple sclerosis.
    Nielsen NM; Jørgensen KT; Stenager E; Jensen A; Pedersen BV; Hjalgrim H; Kjær SK; Frisch M
    Epidemiology; 2011 Jul; 22(4):546-52. PubMed ID: 21516039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cluster of multiple sclerosis patients from Danish community.
    Haahr S; Munch M; Christensen T; Møller-Larsen A; Hvas J
    Lancet; 1997 Mar; 349(9056):923. PubMed ID: 9093258
    [No Abstract]   [Full Text] [Related]  

  • 38. Gender differences in multiple sclerosis epidemiology and treatment response.
    Magyari M
    Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years.
    Setayeshgar S; Kingwell E; Zhu F; Zhang X; Zhang T; Marrie RA; Carruthers R; Tremlett H
    Mult Scler Relat Disord; 2018 Oct; 25():57-60. PubMed ID: 30036855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and social environment and the risk of multiple sclerosis.
    Magyari M; Koch-Henriksen N; Pfleger CC; Sørensen PS
    Mult Scler Relat Disord; 2014 Sep; 3(5):600-6. PubMed ID: 26265272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.